Form 4: TD SYNNEX Director Richard Hume Exercises and Sells Over 63,000 Shares
Insider Transaction Report
TD SYNNEX Director Richard T. Hume executed an option exercise and subsequent sale of 63,310 shares of common stock on June 27, 2025, realizing a significant profit.
Summary
- Richard T. Hume, a Director of TD SYNNEX Corp (SNX), engaged in a series of transactions on June 27, 2025.
- Hume exercised employee stock options to acquire 63,310 shares of common stock at an exercise price of $87.82 per share.
- Immediately following the exercise, Hume sold all 63,310 shares acquired from the option exercise through multiple transactions.
- The sales occurred at weighted average prices ranging from $133.89 to $138.06 per share.
- After these transactions, Hume's direct beneficial ownership of TD SYNNEX common stock stands at 67,515 shares, which is the same number of shares held prior to the option exercise.
- The exercised stock option was granted on October 4, 2022, with a vesting schedule and an expiration date of October 4, 2032.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive because the director realized a significant profit from the option exercise, indicating the stock performed well relative to the option's strike price. However, the immediate sale of all acquired shares prevents a higher score, as it doesn't signal increased confidence in future stock appreciation through holding.
Positives
- The exercise of stock options by a director indicates that the stock price is significantly above the exercise price, suggesting a profitable opportunity for the insider.
- The director realized a substantial gain from the difference between the exercise price ($87.82) and the sale prices (ranging from $133.89 to $138.06).
Negatives
- The immediate sale of all shares acquired from the option exercise, rather than holding them, could be interpreted as the director not increasing their long-term equity stake in the company.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook. It is a report of past insider transactions.
Industry Context
This filing reports an individual insider transaction and does not provide broader industry context or trends. It reflects a director's personal equity management related to their compensation.
Comparison to Industry Standards
- Insider transactions, such as option exercises and subsequent sales, are common practices for executives and directors as part of their compensation and personal financial planning.
- The specific prices and volumes are unique to this individual and company, and direct comparisons to other companies' insider transactions would require detailed analysis of their compensation structures and stock performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Richard Hume granted a Power of Attorney to specific individuals (David Vetter, Wayne Hanewicz, Cheryl Grant, and Maribeth Bautista) to execute and file SEC Forms 3, 4, and 5 on his behalf, and to manage his EDGAR account for electronic filings. | 2025-06-18 | This streamlines the process for the director to comply with Section 16 reporting requirements, ensuring timely and accurate filings by authorized personnel. |
Related Party Transactions
- The transactions reported are between a director and the company's securities, which are inherently related-party transactions in the context of insider reporting. No other specific related party dealings beyond the compensation-related stock transactions are disclosed.
Stakeholder Impact
- Shareholders: The sale of shares by a director could be viewed neutrally or slightly negatively as it does not increase the director's direct equity alignment with shareholders' long-term interests, though it's a common practice for liquidity. The profitability of the option exercise is a positive sign regarding the company's stock performance.
Key Dates
| Date | Description |
|---|---|
| 2022-10-04 | Original grant date for the employee stock option, with vesting commencing on its first anniversary. |
| 2025-06-18 | Date of the Power of Attorney granted by Richard Hume for SEC filings. |
| 2025-06-27 | Date of option exercise and subsequent sale of common stock by Richard T. Hume. |
| 2025-06-30 | Signature date of the Form 4 filing. |
| 2032-10-04 | Expiration date of the employee stock option. |
Keywords
TD SYNNEX, SNX, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Director Transaction, Beneficial Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.